General Other

Acceptance of COVID-19 vaccine is rising. So is pessimism about getting back to normal.

Acceptance of COVID-19 vaccine is rising. So is pessimism about getting back to normal.

Acceptance of the COVID-19 vaccine continues to soar, a new USA TODAY/Suffolk University Poll finds, but pessimism is also on the rise about when things in the United States will get back to normal.

Both results may be signs that the messages from President-elect Joe Biden are being heard. He has taken the vaccine himself, and on camera – something President Trump hasn’t done – and he has also cautioned that the pandemic is going to get worse before it gets better.

Now 56% of those surveyed say they will take the vaccine as soon it was available to them, a jump of 10 percentage points since the USA TODAY poll in December and up a stunning 30 points since October.

Associate Director of Pharmacy Ariane Schieber measures a dose of a COVID-19 vaccine as frontline workers received second doses Tuesday at Ohio State University’s East Hospital.

“The more people that get a vaccination and they see that it’s safe … then more people are willing to go get it,” said Shellie Belapurkar, 50, a nurse-practitioner from Nashua, New Hampshire, who was among those surveyed. She has gotten the vaccine herself and has been volunteering at a clinic each week to give it to others.

“It’s all about education, and I don’t think we’ve educated our population nearly enough to the dangers” of the coronavirus, she said in an interview.

Most of the shift has come from those who were reluctant to take the vaccine before until others had taken it first. Those who expressed that view made up 47% in October, 32% in December and just 22% now.

“When they first announced that the vaccine was available, I was a little bit hesitant,” said Sandi Bethune, 71, a retired training manager for AT&T from Oakland, California. “I was never not going to get it, but I wanted to wait for a while and let some other people be the guinea pigs.” Now, reassured, “as soon as I can take it, I’m taking it.”

But those who declare they will not take the vaccine has barely budged, edging down to 18% now, compared with 20% in October and December.

“There’s so much in it that’s not good for our bodies,” said Brook-lyn Parker, 28, a cosmetologist from Watertown, New York, who said she would never take the shot. “For me, natural immunization is a better way to go as far as COVID goes, kind of like the flu.” As evidence, she noted that she has never gotten the flu vaccine but has caught the flu only twice.

Independent fact-checkers have reported that COVID-19 is much more deadly than the flu, and that relying on so-called “herd immunity” without a vaccine would result in the deaths of millions of Americans.

USA TODAY/Suffolk Poll: Americans, braced for violence at the inauguration, see democracy damaged after Trump

The poll of 1,000 registered voters, taken by landline and cell phone January 11-15, has a margin of error of plus or minus 3.1 percentage points.

Optimism about when things in the United States will get back to normal has ebbed.

In December, a 51% majority predicted things would return to normal by the end of this year. Now just 44% feel that way, down seven points. The proportion who say it will take several years has risen four points, to 31%.

One in five, 20%, asked when the nation will get back to normal, replied “never.”

COVID coverage:: ‘Blood on his hands’: As US nears 400,000 COVID-19 deaths, experts blame Trump administration for a ‘preventable’ loss of life

Where did COVID-19 come from?

Ex-Florida data scientist Rebekah Jones ‘turning herself in’ to face new charge

This article originally appeared on USA TODAY: Poll: COVID vaccine acceptance rises; so does pessimism

About the author

Christine Watkins

Christine founded Sports Grind Entertainment with an aim to bring relevant and unaltered Sports news to the general public with a specific view point for each story catered by the team. She is a proficient journalist who holds a reputable portfolio with proficiency in content analysis and research.

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *